Related Experiment Video
Updated: Mar 30, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway
1a Department of Pediatrics , Allergy, Immunology and Rheumatology, Guangzhou Medical University , Guangdong , China and.
Abstract:
CD2-associated protein is one of the most important slit diaphragm proteins in maintaining podocyte integrity and reducing proteinuria. In the last 15 years, progressive researches have shown that CD2AP serves as an adaptor protein, plays essential roles in the podocyte cytoskeletal structure and signaling from the extracellular SD to the intracellular dynamic actin cytoskeleton. CD2AP deficient or transcript abnormality would lead to podocyte failure and proteinuric glomerular diseases. In this study, we demonstrate that CD2AP and p85 regulatory subunit of phosphoinositide 3-OH kinase (PI3K), recruit PI3K to the plasma membrane, and stimulate PI3K-dependent AKT signaling in podocytes the CD2AP-mediated AKT activity can regulate complex biological programs. PAN reduces Akt phosphorylation levels of GSK3β, LY294002 can promote podocyte apoptosis induced by PAN. Our findings suggest that the activation of PI3K/AKT signaling represents an essential component to maintain the functional integrity of podocytes. And PI3K/Akt signaling pathway play an important role in podocyte apoptosis.
Insights
CD2-associated protein (CD2AP) is crucial for podocyte health and preventing proteinuria. This study reveals CD2AP activates PI3K/AKT signaling, vital for maintaining podocyte integrity and regulating apoptosis.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- CD2-associated protein (CD2AP) is a key slit diaphragm protein essential for podocyte integrity and preventing proteinuria.
- CD2AP acts as an adaptor protein, regulating podocyte cytoskeletal structure and extracellular-to-intracellular signaling.
- CD2AP deficiency or abnormalities cause podocyte dysfunction and proteinuric glomerular diseases.
Purpose of the Study:
- To investigate the role of CD2AP in activating phosphoinositide 3-OH kinase (PI3K)/AKT signaling in podocytes.
- To elucidate how CD2AP-mediated AKT activity influences podocyte function and apoptosis.
Main Methods:
- Investigated the interaction between CD2AP and the p85 regulatory subunit of PI3K.
- Assessed the recruitment of PI3K to the plasma membrane mediated by CD2AP.
- Analyzed the impact of CD2AP on PI3K-dependent AKT signaling and downstream targets like GSK3β.
- Examined the effects of specific inhibitors (PAN, LY294002) on podocyte apoptosis.
Main Results:
- CD2AP and PI3K p85 subunit co-localize and recruit PI3K to the plasma membrane.
- CD2AP activates PI3K-dependent AKT signaling in podocytes.
- CD2AP-mediated AKT activity regulates complex cellular processes, including GSK3β phosphorylation.
- PAN treatment reduces Akt phosphorylation of GSK3β, and LY294002 promotes PAN-induced podocyte apoptosis.
Conclusions:
- Activation of PI3K/AKT signaling is essential for maintaining podocyte functional integrity.
- The PI3K/Akt signaling pathway plays a significant role in regulating podocyte apoptosis.
- CD2AP is a critical regulator of PI3K/AKT signaling, impacting podocyte health and disease.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity

